Aggressive investor
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Health Canada estimates that the country's medical marijuana industry could reach $1.3 billion by 2020, but the recreational marijuana industry could be worth as much as $5 billion per year.
"I have estimated that the legal recreational market could conservatively be $2-4 billion based upon 35 million residents and assuming prices are $7 per gram or so, but I have seen higher estimates," said Brochstein.
http://www.stockhouse.com/companies/bullboard/bullboard/c.sl/supreme-pharmaceuticals-inc#fz12HkZxE5icFoT0.99
Supreme Pharmaceuticals Inc. (CSE: SL) (OTC: SPRWF) is one of the most advanced companies operating in this segment. After completing its pre-license inspection in December, the company is well on its way to securing a license producer status. Its flagship 342,000 square foot greenhouse located in Ontario could provide it with enough scale to become a very low cost producer in the market, offering patients the best overall value.
"Supreme's foundation is to be the premier, large-scale producer of cannabis," said Supreme Pharmaceuticals Inc. CEO John Fowler. "We achieve this in large part through our innovative, hybrid greenhouse production facility. For medical patients this means that supreme can produce affordable medical marijuana with the best dollar value in the market. This should hold true in the recreational market as well."
Pump and dump superstar arrested...
http://www.theotc.today/2015/12/pump-dump-superstar-attorney-jehu-hand.html
Pump and dump superstar arrested...
http://www.theotc.today/2015/12/pump-dump-superstar-attorney-jehu-hand.html
Forget the US, Canada's Cannabis Industry has Big Potential...
Supreme Pharmaceuticals Inc. (CSE: SL) (OTC: SPRWF) is one of the most advanced companies operating in this segment. After completing its pre-license inspection in December, the company is well on its way to securing a license producer status. Its flagship 342,000 square foot greenhouse located in Ontario could provide it with enough scale to become a very low cost producer in the market, offering patients the best overall value.
"Supreme's foundation is to be the premier, large-scale producer of cannabis," said Supreme Pharmaceuticals Inc. CEO John Fowler. "We achieve this in large part through our innovative, hybrid greenhouse production facility. For medical patients this means that supreme can produce affordable medical marijuana with the best dollar value in the market. This should hold true in the recreational market as well."
http://www.baystreet.ca/viewarticle.aspx?id=434881
Pre-inspection for MMPR license requirement done
http://www.marketwired.com/press-release/supreme-announces-pre-license-inspection-date-otc-pink-sprwf-2079271.htm
MMPR from Health Canada announcement anytime, anyday.
http://www.stockhouse.com/news/newswire/2015/12/08/medical-marijuana-update-supreme-gets-date-aurora-gets-license
Forget the US, Canada's Cannabis Industry has Big Potential...
Supreme Pharmaceuticals Inc. (CSE: SL) (OTC: SPRWF) is one of the most advanced companies operating in this segment. After completing its pre-license inspection in December, the company is well on its way to securing a license producer status. Its flagship 342,000 square foot greenhouse located in Ontario could provide it with enough scale to become a very low cost producer in the market, offering patients the best overall value.
"Supreme's foundation is to be the premier, large-scale producer of cannabis," said Supreme Pharmaceuticals Inc. CEO John Fowler. "We achieve this in large part through our innovative, hybrid greenhouse production facility. For medical patients this means that supreme can produce affordable medical marijuana with the best dollar value in the market. This should hold true in the recreational market as well."
http://www.baystreet.ca/viewarticle.aspx?id=434881
Pre-inspection for MMPR license requirement done
http://www.marketwired.com/press-release/supreme-announces-pre-license-inspection-date-otc-pink-sprwf-2079271.htm
MMPR from Health Canada announcement anytime, anyday.
http://www.stockhouse.com/news/newswire/2015/12/08/medical-marijuana-update-supreme-gets-date-aurora-gets-license
Supreme Pharmaceuticals (C.SL) OTC: SPRWF pre-license inspection done... Full licensing from Health Canada announcement anytime....easy double
http://www.stockhouse.com/news/newswire/2015/12/10/supreme-pharmaceuticals-c-sl-pre-license-inspection-done-stock-surging
Canadian exchange
http://cnsx.ca/CNSX/Securities/Life-Sciences/Supreme-Pharmaceuticals-Inc.aspx
Supreme Pharmaceuticals (C.SL) OTC: SPRWF pre-license inspection done... Full licensing from Health Canada announcement anytime....easy double
http://www.stockhouse.com/news/newswire/2015/12/10/supreme-pharmaceuticals-c-sl-pre-license-inspection-done-stock-surging
Canadian exchange
http://cnsx.ca/CNSX/Securities/Life-Sciences/Supreme-Pharmaceuticals-Inc.aspx
Reciprocating same sentiment. thx
Forget the US, Canada's Cannabis Industry has Big Potential
http://www.baystreet.ca/viewarticle.aspx?id=434881
Keep an eye on SPRWF
This Week Could Make or Break Valeant Pharmaceuticals Intl Inc.
https://www.fool.ca/2015/12/14/this-week-could-make-or-break-valeant-pharmaceuticals-intl-inc/
Supreme Completes Pre-License Inspection..
http://money.cnn.com/news/newsfeeds/articles/marketwire/1234740.htm
Supreme Completes Pre-License Inspection..
http://money.cnn.com/news/newsfeeds/articles/marketwire/1234740.htm
Outcome PR perhaps tomorrow
Supreme Announces Pre-License Inspection Date
TORONTO, ONTARIO--(Marketwired - Dec. 3, 2015) - Supreme Pharmaceuticals Inc. (the "Company" or "Supreme") (OTC PINK:SPRWF)(CSE:SL) is pleased to announce Health Canada has scheduled a pre-license inspection of Supreme's hybrid greenhouse facility in Kincardine, Ontario on December 9, 2015.
About Supreme
Supreme is a Canadian publically traded company committed to becoming a leading supplier of affordable medical cannabis achieved by applying commercial agriculture practices to medical cannabis production. Supreme's flagship facility is a 342,000 sq. ft. hybrid greenhouse located in Kincardine, Ontario, which has been designed to maximize production efficiencies allowing the Company to pass savings along to its future patients.""
FORWARD LOOKING INFORMATION
This news release contains forward-looking statements. The use of any of the words "anticipate", "continue", "estimate", "expect", "may", "will", "project", "should", "believe" and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. This news release includes forward-looking statements with respect to the timing on competition of the MMPR License conditions for its Southern Ontario facility and the start of production. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this news release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company's disclosure documents which can be found under the Company's profile on www.sedar.com and such factors as the Company failing to acquire final MMPR licenses and put the same into production. This news release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbour provisions of the Private Securities Litigation Reform Act of 1995.
http://www.marketwired.com/press-release/supreme-announces-pre-license-inspection-date-otc-pink-sprwf-2079271.htm
Outcome PR perhaps tomorrow
Supreme Announces Pre-License Inspection Date
TORONTO, ONTARIO--(Marketwired - Dec. 3, 2015) - Supreme Pharmaceuticals Inc. (the "Company" or "Supreme") (OTC PINK:SPRWF)(CSE:SL) is pleased to announce Health Canada has scheduled a pre-license inspection of Supreme's hybrid greenhouse facility in Kincardine, Ontario on December 9, 2015.
About Supreme
Supreme is a Canadian publically traded company committed to becoming a leading supplier of affordable medical cannabis achieved by applying commercial agriculture practices to medical cannabis production. Supreme's flagship facility is a 342,000 sq. ft. hybrid greenhouse located in Kincardine, Ontario, which has been designed to maximize production efficiencies allowing the Company to pass savings along to its future patients.""
FORWARD LOOKING INFORMATION
This news release contains forward-looking statements. The use of any of the words "anticipate", "continue", "estimate", "expect", "may", "will", "project", "should", "believe" and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. This news release includes forward-looking statements with respect to the timing on competition of the MMPR License conditions for its Southern Ontario facility and the start of production. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this news release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company's disclosure documents which can be found under the Company's profile on www.sedar.com and such factors as the Company failing to acquire final MMPR licenses and put the same into production. This news release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbour provisions of the Private Securities Litigation Reform Act of 1995.
http://www.marketwired.com/press-release/supreme-announces-pre-license-inspection-date-otc-pink-sprwf-2079271.htm
Going to pot? Canada leads way in legalizing marijuana
http://news.yahoo.com/going-pot-canada-leads-way-legalizing-marijuana-173813674.html
Good for Supreme Pharmaceuticals, Inc. OTC: SPRWF CNSX: SL
Going to pot? Canada leads way in legalizing marijuana
http://news.yahoo.com/going-pot-canada-leads-way-legalizing-marijuana-173813674.html
Good for Supreme Pharmaceuticals, Inc. OTC: SPRWF CNSX: SL
New Analyst Rating update on $DVAX
http://www.insidertradingreport.org/analyst-rating-update-on-dynavax-technologies-corporation-nasdaqdvax/6190916/
Hedge Funds Are Buying Dynavax Technologies Corporation $DVAX
http://www.insidermonkey.com/blog/hedge-funds-are-buying-dynavax-technologies-corporation-dvax-396599/
huge news on phase 3 to release anytime
Erin Brockovich: The Biotech Industry Is Jeopardizing Our Health
http://time.com/4129785/erin-brockovich-gmos/
$LPCN presentation today ...
http://ir.lipocine.com/releasedetail.cfm?ReleaseID=944278
$LPCN presentation today ...
http://ir.lipocine.com/releasedetail.cfm?ReleaseID=944278
Oops!!! Repros Therapeutics Receives Complete Response Letter From FDA for Enclomiphene
http://globenewswire.com/news-release/2015/12/01/791998/10157581/en/Repros-Therapeutics-Receives-Complete-Response-Letter-From-FDA-for-Enclomiphene.html#sthash.QP0kkovl.dpuf
Dynavax Technologies Corporation 77.4% Potential Upside Now Implied by RBC Capital Mkts
http://www.directorstalkinterviews.com/dynavax-technologies-corporation-77-4-potential-upside-now-implied-by-rbc-capital-mkts/412685737
Are Analysts Bullish Lipocine Inc (NASDAQ:LPCN) After Last Week?
http://www.financialmagazin.com/are-analysts-bullish-lipocine-inc-nasdaqlpcn-after-last-week/
Are Analysts Bullish Lipocine Inc (NASDAQ:LPCN) After Last Week?
http://www.financialmagazin.com/are-analysts-bullish-lipocine-inc-nasdaqlpcn-after-last-week/
Many Americans Believe They Don't Need The Flu Vaccine ..
http://www.npr.org/sections/health-shots/2015/11/27/456202280/many-americans-believe-they-dont-need-the-flu-vaccine
Many Americans Believe They Don't Need The Flu Vaccine ..
http://www.npr.org/sections/health-shots/2015/11/27/456202280/many-americans-believe-they-dont-need-the-flu-vaccine
$OPXA being set up
as next KBIO and AEZS
Keep an eye
O/S 6.8 million, yesterday traded over 5 million
$OPXA being set up ...
as next KBIO and AEZS
O/S 6.8 million, yesterday traded over 5 million
HEDGE FUNDS LOADING UP WITH MILLIONS IN $LPCN,
How have hedgies been trading Lipocine Inc (NASDAQ:LPCN)?
At the end of the third quarter, a total of 11 of the hedge funds tracked by Insider Monkey held long positions in this stock, a change of -8% from the second quarter. With the smart money’s capital changing hands, there exists a select group of noteworthy hedge fund managers who were boosting their holdings substantially.
When looking at the hedgies followed by Insider Monkey, VHCP Management, managed by Anders Hove and Bong Koh, holds the largest position in Lipocine Inc (NASDAQ:LPCN). VHCP Management has a $15 million position in the stock, comprising 3.9% of its 13F portfolio. The second most bullish hedge fund manager is Royce & Associates, managed by Chuck Royce, which held a $12 million position; 0.1% of its 13F portfolio is allocated to the stock. Some other hedgies that hold long positions include Jacob Gottlieb’s Visium Asset Management, Bihua Chen’s Cormorant Asset Management and Mark Kingdon’s Kingdon Capital.
http://www.insidermonkey.com/blog/is-lipocine-inc-lpcn-a-good-stock-to-buy-385406/
HEDGE FUNDS LOADING UP WITH MILLIONS IN $LPCN,
How have hedgies been trading Lipocine Inc (NASDAQ:LPCN)?
At the end of the third quarter, a total of 11 of the hedge funds tracked by Insider Monkey held long positions in this stock, a change of -8% from the second quarter. With the smart money’s capital changing hands, there exists a select group of noteworthy hedge fund managers who were boosting their holdings substantially.
When looking at the hedgies followed by Insider Monkey, VHCP Management, managed by Anders Hove and Bong Koh, holds the largest position in Lipocine Inc (NASDAQ:LPCN). VHCP Management has a $15 million position in the stock, comprising 3.9% of its 13F portfolio. The second most bullish hedge fund manager is Royce & Associates, managed by Chuck Royce, which held a $12 million position; 0.1% of its 13F portfolio is allocated to the stock. Some other hedgies that hold long positions include Jacob Gottlieb’s Visium Asset Management, Bihua Chen’s Cormorant Asset Management and Mark Kingdon’s Kingdon Capital.
http://www.insidermonkey.com/blog/is-lipocine-inc-lpcn-a-good-stock-to-buy-385406/
Is Lipocine Inc (LPCN) A Good Stock To Buy?
http://www.insidermonkey.com/blog/is-lipocine-inc-lpcn-a-good-stock-to-buy-385406/
Is Lipocine Inc (LPCN) A Good Stock To Buy?
http://www.insidermonkey.com/blog/is-lipocine-inc-lpcn-a-good-stock-to-buy-385406/
$LPCN continuation no ADCOM required and P3 efficacy and safety met goals for first pill in 2billion gel market and gels on generics
$LPCN this uptrend could be serious.